Boston Scientific has launched Expect Endoscopic Ultrasound Aspiration Needle to acquire tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal (GI) tract.
The Expect Needle features an echogenic pattern providing visibility and precise needle guidance within the targeted organ or structure.
Boston Scientific said the cobalt chromium design is engineered to offer improved sharpness and pushability, along with deformation resistance, compared to traditional stainless steel needles.
Medical University of South Carolina in Charleston Gastroenterology and Hepatology Division professor Robert Hawes said combining endoscopic ultrasound with fine needle aspiration offers powerful diagnostic capabilities that can help optimize malignancy management in the GI tract and inform appropriate treatment paths for the patient, including surgery, chemotherapy, radiation or palliation.
The Expect Needle received the US Food and Drug Administration clearance and CE mark earlier this year and is being marketed in the US, Europe and other international markets.